CD34 and congenital bilateral aplasia of vas deferens from CFTR mutation: By deepening our understanding of CD34’s functions and its impact on CAVD pathogenesis, we aim to identify innovative therapeutic strategies that could potentially transform the clinical management of this prevalent and debilitating disease.